Dr(Prof) G C Khilnani - With the rapid rise in Covid-19 cases recently, there is a case for using this medicine in susceptible populations who are at high risk of severe disease, death and post covid complications, , REDUCING SEVERITY, Post-COVID complications, Long COVID, COVID-19